Snapshot of the Global Therapeutic Landscape of Pseudomonas aeruginosa Infections to Deliver by Research Available at The Market Reports

Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Pseudomonas aeruginosa Infections – Pipeline Review, H1 2018, provides an overview of the Pseudomonas aeruginosa Infections (Infectious Disease) pipeline landscape.

Pune, India – March 29, 2018 /MarketersMedia/ —

Pseudomonas aeruginosa has become an important cause of infection, especially in patients with compromised host defense mechanisms. It has an ability to rapidly develop resistance to multiple classes of antibiotics. It is the most common pathogen isolated from patients who have been hospitalized for more than one week. Signs and symptoms include pneumonia, fever, fatigue, itchy rash, bleeding ulcers and headache. Risk factors include age and weakened immune system.
Report Source: https://www.themarketreports.com/report/pseudomonas-aeruginosa-infections-pipeline-review-h1-2018
Scope
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Pseudomonas aeruginosa Infections (Infectious Disease) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Pseudomonas aeruginosa Infections (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Pseudomonas aeruginosa Infections (Infectious Disease)
Purchase this report at: https://www.themarketreports.com/report/buy-now/1036786
The Pseudomonas aeruginosa Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pseudomonas aeruginosa Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 4, 2, 6, 57, 23 and 2 respectively. Similarly, the Universities portfolio in Preclinical, Discovery and Unknown stages comprises 12, 14 and 1 molecules, respectively.
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/1036786

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/snapshot-of-the-global-therapeutic-landscape-of-pseudomonas-aeruginosa-infections-to-deliver-by-research-available-at-the-market-reports/322610

For more information, please visit https://www.themarketreports.com/report/pseudomonas-aeruginosa-infections-pipeline-review-h1-2018%20%20

Source: MarketersMedia

Release ID: 322610